Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

JAN

JanOne (JAN)

JanOne Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:JAN
日付受信時刻ニュースソース見出しコード企業名
2024/05/1705 : 00PR Newswire (US)JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain FintechNASDAQ:JANJanOne Inc
2024/05/1320 : 30PR Newswire (US)JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology ProviderNASDAQ:JANJanOne Inc
2024/05/1105 : 10PR Newswire (US)JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology ProviderNASDAQ:JANJanOne Inc
2024/05/0705 : 59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2024/05/0705 : 57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANJanOne Inc
2024/03/1522 : 00PR Newswire (US)JanOne Regains Compliance with Nasdaq's Listing RequirementsNASDAQ:JANJanOne Inc
2024/02/2906 : 22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2024/02/1002 : 36Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
2024/02/0906 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2024/01/1306 : 28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/10/1205 : 33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/09/2306 : 00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
2023/09/2200 : 30PR Newswire (US)JanOne to Present at the Dawson James 8th Annual Investment ConferenceNASDAQ:JANJanOne Inc
2023/09/2122 : 35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:JANJanOne Inc
2023/09/1605 : 33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/09/0102 : 30PR Newswire (US)JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment ConferenceNASDAQ:JANJanOne Inc
2023/08/3002 : 30PR Newswire (US)JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic PainNASDAQ:JANJanOne Inc
2023/08/2906 : 20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JANJanOne Inc
2023/08/2603 : 30PR Newswire (US)JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
2023/08/2505 : 30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:JANJanOne Inc
2023/08/2405 : 33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/08/2306 : 30PR Newswire (US)JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
2023/08/2301 : 54Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANJanOne Inc
2023/08/1908 : 00PR Newswire (US)JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
2023/08/1901 : 42PR Newswire (US)JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
2023/08/1704 : 55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JANJanOne Inc
2023/08/1605 : 39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JANJanOne Inc
2023/07/0805 : 19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
2023/07/0105 : 24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/06/2821 : 30PR Newswire (US)JanOne files international patent application for methods of using low dose naltrexone to treat chronic painNASDAQ:JANJanOne Inc
 Showing the most relevant articles for your search:NASDAQ:JAN

最近閲覧した銘柄

Delayed Upgrade Clock